Abstract
The global fava beans market valuation was 3.9 (USD Billion) in 2019 and is projected to grow at a CAGR of nearly 2.1% during the period from 2019 to 2025. The report offers valuation and analysis of the fava beans market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, revenue estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Billion).
Introduction
Fava beans are consumed across the globe and consist of polyphenols & I-DOPA (I-3-4-dihydroxyphenylalanine). According to NCBI, the antioxidant screening program performed by it in 2016 had demonstrated that fava beans sprout possessed higher antioxidant properties as compared to any other sprouts or matured beans.
Furthermore, fava beans comprise compounds such as convicine and vicine. Moreover, these chemicals are further metabolized to divicine & isouramil which are strong oxidizing agents. Additionally, isouramil and divicine have almost the same metabolic effects.
Key Growth Drivers
Fava beans also referred to as vicia faba comprises of dihydroxyphenylalanine and the intake of these products is expected to increase dopamine stores. Furthermore, renal dopamine helps in regulating blood volume through the natriuretic effect along with controlling blood pressure. All these aforementioned features of the product are expected to define the growth of the fava beans market over the forecast timeline.
Moreover, the fava bean is a unique legume yield and possesses high nutritive value content such as starch & protein. Additionally, it is a unique source of protein, lecithin, complex carbohydrates, choline, minerals, and phenolic. This will further generate demand for the product over the forthcoming years. Apparently, in comparison to cereals, fava beans contain large proportions of arginine and lysine.
Apart from the huge agricultural potential of fava beans, it also possesses high industrial value due to the huge content of the L-dopa ingredient. Furthermore, the intake of fava beans can raise the proportion of L-dopa in blood, thereby resulting in a tremendous enhancement in the motor performance of the people suffering from Parkinson's ailment. Additionally, the fava bean consumption does not have any side effects on the health of the patient. All these abovementioned factors will chart a profitable roadmap for the fava beans industry over the forecasting years.
North American Market To Garner Major Share Over Forecast Period
The growth of the regional market over the forecast period is owing to large-scale intake of plant-based protein food products in countries like the U.S. and Canada. Furthermore, growing concerns raised by the population of these countries over lactose intolerance & glutamic disorder will have a favorable impact on the fava beans utilization. Apparently, the need to reduce the high obesity rate in countries like the U.S. will impel the growth of the regional market over the forecast period.
Key players profiled in our market research report include GrainCorp Limited, Dunns (Long Sutton) Limited, Nuttee Bean Co., Sun Impex B.V., BI Nutraceuticals, and Prairie Fava.
The global fava beans market is segmented as follows:
By Application
Human Nutrition
Animal Feed
By Distribution Channel
Online
Offline
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa